This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Endocrine Dysfunction and Quality of Life After Subarachnoid Hemorrhage

This study has been completed.
Information provided by (Responsible Party):
Erik Kronvall, Lund University Hospital Identifier:
First received: April 8, 2010
Last updated: September 6, 2012
Last verified: September 2012
Investigation of the incidence of endocrine dysfunction following subarachnoid hemorrhage (SAH), and to see if this has a relation to CNS lesions as evaluated by MRI and to common symptoms after SAH such as general exhaustion, lack of initiative, increased sleep demand and reduced quality of life.

Endocrine Dysfunction Cerebral Infarctions Quality of Life

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Endocrine Dysfunction and Quality of Life After Subarachnoid Hemorrhage

Resource links provided by NLM:

Further study details as provided by Erik Kronvall, Lund University Hospital:

Biospecimen Retention:   None Retained
Blood and urine samples

Estimated Enrollment: 50
Study Start Date: November 2006
Study Completion Date: September 2012
Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Patients with subarachnoid hemorrhage


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients from the southern part of Sweden who have suffered subarachnoid hemorrhage and admitted to the Department of Neurosurgery in Lund

Inclusion Criteria:

  • acute aneurysmal subarachnoid hemorrhage

Exclusion Criteria:

  • unable to give informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01101711

Department of Neurosurgery
Lund, Sweden
Sponsors and Collaborators
Lund University Hospital
  More Information

Responsible Party: Erik Kronvall, Dr., Lund University Hospital Identifier: NCT01101711     History of Changes
Other Study ID Numbers: 65/2006
Study First Received: April 8, 2010
Last Updated: September 6, 2012

Additional relevant MeSH terms:
Subarachnoid Hemorrhage
Cerebral Infarction
Pathologic Processes
Intracranial Hemorrhages
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Brain Infarction
Brain Ischemia
Stroke processed this record on June 23, 2017